ABSTRACT
Introduction
Rosmarinus officialis is popularly known in Brazil as rosemary 1 . The presence of rosmarinic acid (RA) in medicinal plants, herbs and spices, has been generated healthy and beneficial effects. Among these were several RA biological activities, including antioxidant, astringent, anti-inflammatory, antimicrobial, antiangiogenic, antiviral, antirheumatic, antiallergic, antidepressant, antidiabetic, and antitumor [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . However, reports on its activity in the cardiovascular system are scarce.
Methods

A MEDLINE database search (from January 1970 to
December 2011) using only rosmarinic acid as searched term. It is necessary to view the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/ reperfusion injury ( Figure 2 ). This is the rationale of the present review. . Rosmarinic acid and cardiovascular diseases
Results
A MEDLINE database search (until
Discussion
Rosmarinic acid pharmacological properties
Cardiomyopathy
The study used melaton to induce rat cardiopathology.
The administration of luteolin and echinochrome provided to 100% animal probability of survival. At the same time, mitochondrial apparatus of cardiomyocytes was characterized by the normal parameter, therefore, given preparations have provided of a protective effect at cardiomyocytes level. However, similar activities for rosmarinic acid have not shown 16 .
Other study was undertaken to investigate the However, literature reports about its activity in the cardiovascular system are scarce.
The RA effect on BP could be related to inhibition and/ or modulation of ACE, as shown by Li et al. 21 and Karthik et al. 
Conclusions
As RA is, nowadays, investigated in our laboratory, we carried out the presented MEDLINE search, and, it was a surprise the number of references about cardiovascular diseases. So we planned to share our uncertainty illustrated on the text title: does rosmarinic acid underestimate as a cardiovascular current drug?
We trust that it is because we are getting satisfactory results on rat models of hypertension. In an overview, we hypothesize that AR deserves more experimental and clinical research in the cardiovascular milieu.
